Search for Johnson & Johnson Co Inc and
    1. December 10, 2014

      Digital future signals more active role for the patient

      Healthcare has been slower than other industries to feel the full force of digital technology. Whereas everyday activities...

    2. November 17, 2014

      GlaxoSmithKline leads Access to Medicine Index

      GlaxoSmithKline is leading the pharmaceuticals industry in efforts to widen global access to medicines, according to a...

    Special Reports

    1. Combating Cancer

      A wave of drugs that harnesses the body’s immune system is fuelling optimism that scie...
    2. Combating Hepatitis C

      Treatment for the virus is in the midst of its biggest advance for at least a decade a...
    Search more Special Reports on this topic.

    1. November 7, 2014

      US earnings boost masks revenue fears

      Beating earnings expectations has long been the game played by companies and Wall Street. And the latest results season has...

    2. November 5, 2014

      Sweeteners, incentives – and abundant water supplies – help draw multinationals to Wallonia

      Wallonia is usually promoted on the basis of its location, its easy access to European and global communication networks and...

    3. November 4, 2014

      AstraZeneca strikes deals on cancer drugs

      AstraZeneca struck two deals on Tuesday aimed at strengthening its position in cancer drugs, as the UK pharmaceuticals group...

    4. October 23, 2014

      Industry response to Ebola quickens

      Pharmaceutical executives and international donors were thrashing out details of a push to accelerate development of...

    5. October 22, 2014

      GSK expects first doses of Ebola vaccine ready by year end

      GlaxoSmithKline said it expected to have the first doses of its experimental Ebola vaccine ready by the end of this year, as...

    6. October 16, 2014

      Pharma giants face developing market ambitions

      As the pharmaceuticals industry careered towards the edge of its notorious patent cliff over the past decade, there was one...

    7. October 14, 2014

      J&J slips despite upbeat forecasts

      US pharmaceutical companies are set to report earnings in coming weeks and Johnson & Johnson has kicked things off by...

    8. October 9, 2014

      War waged on scourge of the lesser known diseases

      It is one of Africa’s most feared diseases with symptoms including fever, swelling of internal organs and skin lesions. If...

    9. October 3, 2014

      Guinter Kahn, dermatologist, 1934-2014

      Scientists have been seeking a cure for baldness since the dawn of modern medicine. Hippocrates experimented with a...

    10. September 26, 2014

      Drug development: Big pharma back in the game it made

      Big pharma is back. That, at least, is the impression created by a wave of new cancer drugs rapidly approaching market....

    11. August 25, 2014

      Chi-Med draws on the past for the future

      Hutchison China MediTech represents the past and the future of China’s pharmaceuticals industry. Much of its revenues come...

    12. July 27, 2014

      Hepatitis C researchers battle to ‘nuke’ the competition

      Idenix has fewer than 100 employees and no products on the market. So what was it that persuaded Merck to pay $3.85bn – more...

    13. June 18, 2014

      David Cameron launches world’s biggest dementia study

      The world’s biggest study of dementia will be unveiled by David Cameron on Thursday as part of a push worth more than £100m...

    14. June 16, 2014

      Medical device makers in a race to merge

      Medical device companies are eyeing more consolidation after Medtronic agreed to buy Covidien in a $42.9bn deal that...

    15. June 12, 2014

      US tech and pharma park cash offshore

      ‘Golden age’ for offshore cash A group of leading US technology and pharmaceutical companies including Microsoft, Google and...

    16. June 12, 2014

      Taxing time ahead as offshore rules come under more scrutiny

      ‘Golden age’ for offshore cash The OECD called it “the golden age” of tax planning: a period in which multinational...

    17. May 14, 2014

      GSK in China: when in doubt, do nothing

      Authorities in China say that GlaxoSmithKline’s Chinese subsidiary paid bribes on a massive scale and that the orders to do...

    18. April 9, 2014

      Price of hepatitis C drug attacked

      Gilead Sciences is facing mounting pressure over its new $1,000-a-day hepatitis C drug after the World Health Organisation...

    19. April 1, 2014

      Drugmakers learn to blend commerce with philanthropy in Africa

      Africa has rarely been a source of good publicity for big pharma. But two events this week suggest the drugs industry is...

    20. March 14, 2014

      Alejandro Zaffaroni, life scientist and entrepreneur, 1923-2014

      As the second world war drew to a close in 1945, Alejandro Zaffaroni hitched a ride on a US military cargo ship from his...

    21. March 11, 2014

      Big pharma lobbies for more poppies as painkiller demand surges

      Big pharma has warned Australia to expand its poppy growing industry beyond the remote island of Tasmania amid fears the...

    22. March 10, 2014

      Reckitt Benckiser to buy K-Y lubricants

      Reckitt Benckiser, the UK producer of Durex condoms, is to buy the K-Y brand of sexual lubricants as it increases its focus...

    23. January 21, 2014

      J&J sees ‘exceptional’ growth amid drug successes

      Johnson & Johnson trumpeted “exceptional” growth in its pharmaceuticals business on Tuesday as the US healthcare group reaps...

    24. January 16, 2014

      Carlyle joins M&A flurry with J&J unit purchase

      Carlyle, the private equity firm, has bought a unit of healthcare company Johnson & Johnson in a $4.15bn deal, joining the...

    25. December 26, 2013

      Ethics: End of the hard sell?

      When Johnson & Johnson wanted to boost prescriptions of Natrecor, a heart medicine, it channelled more than $100,000 through...

    26. December 24, 2013

      Carlyle in exclusive talks to buy J&J blood testing unit

      Carlyle has entered exclusive talks with Johnson & Johnson to buy its blood testing unit in what would be about a $4bn deal,...

    27. December 12, 2013

      Avon: Hard to cover up

      A job promotion seems like a good idea at the time. Yet it is natural to wonder if Sheri McCoy regrets taking over the chief...

    28. December 11, 2013

      J&J and Novartis mull appeal against €16m EU fines

      Johnson & Johnson and Novartis are considering whether to appeal against EU antitrust fines of €16m imposed this week for...

    29. December 2, 2013

      Big companies in end-of-year bond rush

      Large corporate borrowers seeking to raise the last batch of funding for 2013 could sell close to $30bn in investment-grade...

    30. November 20, 2013

      J&J to pay $2.5bn to settle suits over faulty artificial hips

      Johnson & Johnson has agreed to pay $2.5bn to settle claims from 8,000 US patients who used artificial hips made by its...

    31. MBA blog

      November 18, 2013

      Transforming ideas into impact

      After nine months of planning and recruiting, this past weekend my colleagues at MIT Chief and I finally hosted the 3rd...

    32. FT Alphaville

      November 5, 2013

      The (early) Lunch Wrap

      Good morning New York, FT ALPHAVILLE Spot the industry plagued by wrongdoing and huge fines: The fine that really made Dan...

    33. FT Alphaville

      November 5, 2013

      Spot the industry plagued by wrongdoing and huge fines

      No, not everybody’s favourite inside trading hedge fund. The fine that really made us gasp this week was the $2.2bn penalty...

    34. November 4, 2013

      J&J’s enterprising sales staff

      Selling Johnson & Johnson’s antipsychotic medicine to children was neither easy nor legal a decade ago, but enterprising...

    35. November 4, 2013

      J&J hit by fines of more than $2.2bn

      Johnson & Johnson is to pay more than $2.2bn in fines to US federal and state authorities for kickbacks and promotion of its...

    36. November 3, 2013

      Women at business school – Jessica Smith, associate director of MBA admissions

      Jessica Smith is associate director of MBA Admissions and head of career services for Iese Business School in North America....

    37. October 2, 2013

      Johnson & Johnson: never say never

      Johnson & Johnson will never break up. Its focus on continuity is acute. The current boss has been at the company for 25...

    38. September 29, 2013

      Pregnancy apps raise fresh privacy concerns

      The computer engineers at BabyCenter are often among the first people women tell they are pregnant. Mothers-to-be go to...

    Search for Johnson & Johnson Co Inc and